학술논문

Riboflavine and severe lactic acidosis.
Document Type
Case Study
Source
Lancet. 3/13/1999, Vol. 353 Issue 9156, p901-902. 2p. 1 Graph.
Subject
*PATHOLOGICAL physiology
*LACTIC acid
*REVERSE transcriptase
*VITAMIN B2
*HIV-positive women
*CHEMICAL inhibitors
*PHYSIOLOGY
*VITAMIN therapy
*THERAPEUTICS
Language
ISSN
0140-6736
Abstract
States that a major breakthrough in the pathophysiology of nucleoside reverse-transcriptase inhibitors (NRTI)-associated disorder was achieved by Fouty et al who found riboflavin deficiency in three patients with lactic acidosis and liver steatosis. Rapid recovery made by a pregnant, HIV-1 infected woman after treatment with riboflavin; Conclusion.